Macular Degeneration Treatment Market (Disease Indication: Wet Age-related Macular Degeneration, Dry Age-related Macular Degeneration, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Sep 2022| TMR1360B| Transparency

Report Highlights

Macular Degeneration Treatment Market – Scope of Report

TMR’s report on the global macular degeneration treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global macular degeneration treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global macular degeneration treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the macular degeneration treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global macular degeneration treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global macular degeneration treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global macular degeneration treatment market.

The report delves into the competitive landscape of the global macular degeneration treatment market. Key players operating in the global macular degeneration treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global macular degeneration treatment market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market macular degeneration treatment.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 2 : Global Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 3 : Global Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 4 : Global Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 6 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 7 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 8 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 9 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 10 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 11 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 12 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 13 : Asia Pacific Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 14 : Asia Pacific Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 15 : Asia Pacific Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 16 : Asia Pacific Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 18 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 19 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 20 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 21 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031
  • Table 22 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 23 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 24 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Figure 1 : Global Macular Degeneration Treatment Market Snapshot
  • Figure 2 : Global Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 3 : Global Macular Degeneration Treatment Market Value Share, by Disease Indication, 2021
  • Figure 4 : Global Macular Degeneration Treatment Market Value Share, by Drug Class, 2021
  • Figure 5 : Global Macular Degeneration Treatment Market Value Share, by Distribution Channel, 2021
  • Figure 6 : Global Macular Degeneration Treatment Market Value Share, by Region, 2021
  • Figure 7 : Global Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 8 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Wet AMD, 2017–2031
  • Figure 9 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Dry AMD, 2017–2031
  • Figure 10 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Other Indications, 2017–2031
  • Figure 11 : Global Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 12 : Global Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2021 and 2031
  • Figure 13 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Anti-vascular Endothelial Growth Factor, 2017–2031
  • Figure 14 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2031
  • Figure 15 : Global Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 16 : Global Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 17 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2031
  • Figure 18 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Ophthalmology Clinics, 2017–2031
  • Figure 19 : Global Macular Degeneration Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2017–2031
  • Figure 20 : Global Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 21 : Macular Degeneration Treatment Market Value Share Analysis, by Region, 2017 and 2031
  • Figure 22 : Macular Degeneration Treatment Market Attractiveness Analysis by Region, 2022–2031
  • Figure 23 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 24 : North America Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2017 and 2031
  • Figure 25 : North America Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 26 : North America Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 27 : North America Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 28 : North America Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 29 : North America Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 30 : North America Macular Degeneration Treatment Market Value Share Analysis, by Country, 2017 and 2031
  • Figure 31 : North America Macular Degeneration Treatment Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 32 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 33 : Europe Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2017 and 2031
  • Figure 34 : Europe Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 35 : Europe Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 36 : Europe Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 37 : Europe Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2021–2031
  • Figure 38 : Europe Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 39 : Europe Macular Degeneration Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 40 : Europe Macular Degeneration Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 41 : Asia Pacific Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 42 : Asia Pacific Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2017 and 2031
  • Figure 43 : Asia Pacific Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 44 : Asia Pacific Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 45 : Asia Pacific Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 46 : Asia Pacific Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 47 : Asia Pacific Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 48 : Asia Pacific Macular Degeneration Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 49 : Asia Pacific Macular Degeneration Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 50 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 51 : Latin America Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2017 and 2031
  • Figure 52 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 53 : Latin America Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 54 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 55 : Latin America Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 56 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 57 : Latin America Macular Degeneration Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 58 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 59 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 60 : Middle East & Africa Macular Degeneration Treatment Market Value Share Analysis, by Drug Class, 2017 and 2031
  • Figure 61 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis, by Drug Class, 2022–2031
  • Figure 62 : Middle East & Africa Macular Degeneration Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 63 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 64 : Middle East & Africa Macular Degeneration Treatment Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 65 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 66 : Middle East & Africa Macular Degeneration Treatment Market Value Share Analysis, by Country, 2017 and 2031
  • Figure 67 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis, by Country, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

Macular Degeneration Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Date - Feb 2019
  • Code - TMR1360A

Macular Degeneration Treatment Market: Overview

This report on the global macular degeneration treatment market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on disease indication, drug class, distribution channel, and region. ...

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS